Filed before 2025Filed 27 February 2019
Oyster Point Pharma, Inc. raised $85M
Oyster Point Pharma, Inc., a pharmaceuticals company based in Princeton, NJ, raised $85M in a new equity round, according to a filing dated 27 February 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 27 February 2019
- Round
- Equity round
- Amount sold
- $85M
- Offering size
- $93M
- Investors so far
- 7
- Based in
- Princeton, NJ
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 96% of the 1,781 tracked raises with an amount filed in 2019, and than 91% of the 33 in pharmaceuticals.
Oyster Point Pharma, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 27 Feb 2019 | New filing | $85M | This raise |
| 25 Oct 2017 | New filing | $28.6M | Another raise |
More with NEA on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.